Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Traws Pharma, Inc. TRAW

Full chart Compare
Set alert

Price alert · TRAW

All alert types
0.23 USD +0.01 (+2.95%)

Nov 6, 2026, 2:52 PM EST

0.221 Day range 0.2384
0.22 52-week range 3.23
YTD
-79.95%
1 year
-88.84%

Financial health

Altman Z-Score

-117.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 1.4×
FY 2016: -0.5×FY 2017: -0.6×FY 2018: -0.4×FY 2019: -0.3×FY 2020: -3.3×FY 2021: -2.7×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -0.3×FY 2025: 1.4×
FY 2016 5y median -0.7× FY 2025
P/S 3.3×
FY 2016: 1.8×FY 2017: 17.2×FY 2018: 7.1×FY 2019: 2.5×FY 2020: 354×FY 2021: 190×FY 2022: 60.1×FY 2023: 69.7×FY 2024: 61.0×FY 2025: 3.3×
FY 2016 5y median 61.0× FY 2025
P/B -14.8×
FY 2016: 2.3×FY 2017: -1.2×FY 2018: 1.6×FY 2019: 0.5×FY 2020: 13.2×FY 2021: 0.9×FY 2022: 0.5×FY 2023: 1.5×FY 2024: -0.4×FY 2025: -14.8×
FY 2016 5y median 0.5× FY 2025
P/FCF -0.4×
FY 2016: -0.6×FY 2017: -0.6×FY 2018: -0.4×FY 2019: -0.3×FY 2020: -3.5×FY 2021: -2.2×FY 2022: -0.8×FY 2023: -0.9×FY 2024: -0.5×FY 2025: -0.4×
FY 2016 5y median -0.8× FY 2025
EV/EBITDA -0.3×
FY 2016: 0.6×FY 2017: -0.4×FY 2018: 0.4×FY 2019: 0.8×FY 2020: -2.5×FY 2021: 0.7×FY 2022: 1.3×FY 2023: 0.3×FY 2024: 0.0×FY 2025: -0.3×
FY 2016 5y median 0.3× FY 2025
EV/Sales 2.0×
FY 2016: -2.1×FY 2017: 12.0×FY 2018: -6.7×FY 2019: -7.9×FY 2020: 272×FY 2021: -53.8×FY 2022: -111×FY 2023: -22.5×FY 2024: -33.4×FY 2025: 2.0×
FY 2016 5y median -33.4× FY 2025
FCF Yield -223.4%
FY 2016: -157.4%FY 2017: -176.4%FY 2018: -260.8%FY 2019: -382.1%FY 2020: -28.2%FY 2021: -45.4%FY 2022: -119.9%FY 2023: -114.0%FY 2024: -216.1%FY 2025: -223.4%
FY 2016 5y median -119.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 94.7%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -640.7%
FY 2016: -427.4%FY 2017: -3270.3%FY 2018: -1895.9%FY 2019: -994.0%FY 2020: -10819.5%FY 2021: -7299.1%FY 2022: -8684.5%FY 2023: -8981.4%FY 2024: -21835.4%FY 2025: -640.7%
FY 2016 5y median -8684.5% FY 2025
Net Margin 328.7%
FY 2016: -354.6%FY 2017: -3061.2%FY 2018: -1675.3%FY 2019: -985.0%FY 2020: -10890.5%FY 2021: -7151.8%FY 2022: -8391.2%FY 2023: -8384.1%FY 2024: -24192.0%FY 2025: 328.7%
FY 2016 5y median -8384.1% FY 2025
ROE -1457.9%
FY 2016: -457.7%FY 2017: 206.1%FY 2018: -381.9%FY 2019: -185.8%FY 2020: -407.4%FY 2021: -35.0%FY 2022: -67.0%FY 2023: -177.5%FY 2024: 172.9%FY 2025: -1457.9%
FY 2016 5y median -67.0% FY 2025
ROIC 3379.0%
FY 2016: -181.3%FY 2017: 515.0%FY 2018: -244.0%FY 2019: -141.1%FY 2020: -250.8%FY 2021: -33.4%FY 2022: -62.7%FY 2023: -150.8%FY 2024: -367.5%FY 2025: 3379.0%
FY 2016 5y median -62.7% FY 2025
ROA 86.4%
FY 2016: -84.7%FY 2017: -483.9%FY 2018: -114.8%FY 2019: -90.8%FY 2020: -125.9%FY 2021: -29.1%FY 2022: -48.2%FY 2023: -83.5%FY 2024: -219.0%FY 2025: 86.4%
FY 2016 5y median -48.2% FY 2025

Growth (YoY)

Revenue 1134.5%
FY 2016: -51.6%FY 2017: -85.8%FY 2018: 56.0%FY 2019: 77.8%FY 2020: -89.4%FY 2021: -2.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 1134.5%
FY 2016 FY 2025
Operating Income 63.8%
FY 2016: 1.1%FY 2017: -8.6%FY 2018: 9.5%FY 2019: 6.8%FY 2020: -15.2%FY 2021: 34.0%FY 2022: -19.0%FY 2023: -3.4%FY 2024: -143.1%FY 2025: 63.8%
FY 2016 FY 2025
EPS (diluted) 102.3%
FY 2016: 57.7%FY 2017: 39.7%FY 2018: 87.6%FY 2019: 70.0%FY 2020: 90.3%FY 2021: 55.7%FY 2022: 5.5%FY 2023: 0.5%FY 2024: -56.0%FY 2025: 102.3%
FY 2016 FY 2025
Free Cash Flow 30.3%
FY 2016: 49.5%FY 2017: -50.6%FY 2018: 4.7%FY 2019: 8.0%FY 2020: -10.6%FY 2021: 15.6%FY 2022: 16.4%FY 2023: -10.1%FY 2024: -66.0%FY 2025: 30.3%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 2.3×FY 2017: 0.5×FY 2018: 2.1×FY 2019: 2.8×FY 2020: 2.0×FY 2021: 9.1×FY 2022: 4.9×FY 2023: 2.5×FY 2024: 2.2×FY 2025: 0.7×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 0.7×
FY 2016: 2.3×FY 2017: 0.5×FY 2018: 2.1×FY 2019: 2.8×FY 2020: 1.9×FY 2021: 9.1×FY 2022: 4.9×FY 2023: 2.5×FY 2024: 2.2×FY 2025: 0.7×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 1.1×FY 2017: 0.2×FY 2018: 0.8×FY 2019: 1.0×FY 2020: 0.8×FY 2021: 3.3×FY 2022: 2.0×FY 2023: 1.0×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31